-The Hindu     In spite of the rosy picture painted by the World Bank, the prospect of eliminating extreme poverty remains distant In a protracted period of gloom and persistent recession with feeble signs of recovery in a large part of the developed world, the World Bank, Brookings Institution and others can be forgiven for their euphoria over the accomplishment of a key Millennium Development Goal (MDG) - of halving extreme poverty in...

-The Times of India So much has already been written on the food security Bill that there would seem to be no justification for another column on it. Yet, a recent look at some consumption data has convinced me otherwise. How the food security Bill impacts people's lives ultimately depends on the effect it will have on the consumption basket of the beneficiaries. If you believe in serious analysis over flag waving,...

-The Hindu   Investment in a scheme that guarantees rural employment with minimum wages should be seen as complementary and not alternative to development activities A recent paper by the Commission for Agricultural Costs and Prices (CACP) has argued that the "push" factors of the Mahatma Gandhi National Rural Employment Guarantee Act (MGNREGA) are not as important as the economic growth "pull" factors, for increasing agricultural wages. The paper has received wide media...

-The Hindu Business Line   The Bill does not take into account the extremely varied nature of land markets. It looks like the Land Acquisition, Rehabilitation And Resettlement Bill is going to be finally presented in Parliament for passage in the current session. The full details of what is in the current Bill aren't known because over 150 amendments may have been made to the last version that was available for public scrutiny. But...

-The Hindu The Supreme Court judgment on Glivec is a blow for a patent regime with a higher threshold of inventiveness On April 1, 2013, the Supreme Court upheld the Intellectual Property Appellate Board's decision to deny patent protection to Novartis's application covering a beta crystalline form of imatinib -the medicine Novartis brands as Glivec, and which is very effective against the form of cancer known as chronic myeloid leukaemia (CML). The...